Anti-PSME1 antibody [EPR10967(B)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(4 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal PSME1 antibody. Suitable for WB, I-ELISA, ICC/IF and reacts with Human samples. Cited in 7 publications.
View Alternative Names
IFI5111, PSME1, Proteasome activator complex subunit 1, 11S regulator complex subunit alpha, Activator of multicatalytic protease subunit 1, Interferon gamma up-regulated I-5111 protein, Proteasome activator 28 subunit alpha, REG-alpha, IGUP I-5111, PA28a, PA28alpha
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
Immunofluorescent analysis of MCF7 cells labeling PSME1 with ab155091 at 1/100 dilution.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
Immunocytochemistry/Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) labeling PSME1 with purified ab155091 at 1/500 dilution. Cells were fixed with 4% PFA and permeabilized with 0.1% tritonX-100. ab150077 Goat anti rabbit IgG (Alexa Fluor®488) at 1/1000 was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.
- I-ELISA
Lab
Indirect ELISA - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
Indirect ELISA analysis of Human Proteasome activator complex subunit 1 using ab155091 at 1000 ng/mL dilution and secondary Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 2500 ng/mL dilution
- WB
Lab
Western blot - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
Lanes 1-4 : Merged signal (red and green). Green - ab155091 observed at 29 kDa. Red - loading control ab8245 observed at 36 kDa.
ab155091 Anti-PSME1 antibody [EPR10967(B)] was shown to specifically react with PSME1 in wild-type HEK-293T cells. Loss of signal was observed when knockout cell line ab266192 (knockout cell lysate ab257613) was used. Wild-type and PSME1 knockout samples were subjected to SDS-PAGE. ab155091 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PSME1 antibody [EPR10967(B)] (ab155091) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
PSME1 knockout HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
Western blot - Human PSME1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-psme1-knockout-hek-293t-cell-line-ab266192'>ab266192</a>)
Lane 3:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
- WB
Unknown
Western blot - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
All lanes:
Western blot - Anti-PSME1 antibody [EPR10967(B)] (ab155091) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP conjugated at 1/2000 dilution
Predicted band size: 29 kDa
false
- WB
AbReview40987****
Western blot - Anti-PSME1 antibody [EPR10967(B)] (AB155091)
All lanes:
Western blot - Anti-PSME1 antibody [EPR10967(B)] (ab155091) at 1/1000 dilution
All lanes:
Human prostate cancer whole tissue lysate at 20 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/5000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
true
Exposure time: 2min
This image is courtesy of an anonymous Abreview
Related conjugates and formulations (1)
-
Anti-PSME1 antibody [EPR10967(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PSME1 modulates protein degradation processes and participates as a component of the immunoproteasome. The immunoproteasome is a complex that processes peptides for presentation on MHC class I molecules vital for immune response. This involvement transforms PSME1 into an important player in antigen processing and presentation influencing T-cell activation and immune surveillance. PSME1 affects immune system adaptability and efficiency impacting infection response and immune regulation.
Pathways
PSME1 is a significant participant in the ubiquitin-proteasome system and the MHC class I antigen processing pathway. It directly interacts with other proteasome components like the catalytic 20S core and the 11S regulator. The interplay with these proteins steers the precision and output of antigenic peptides essential for T-cell mediated immune recognition. By influencing these pathways PSME1 links the protein degradation machinery to adaptive immunity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Molecular cancer therapeutics 23:1743-1760 PubMed39210605
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell 186:5411-5427.e23 PubMed37918396
2023
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 2:100526 PubMed34027484
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of lipid and atherosclerosis 10:223-239 PubMed34095014
2021
Applications
Unspecified application
Species
Unspecified reactive species
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20:399-410 PubMed31595669
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature microbiology 4:933-940 PubMed30886358
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 291:13147-59 PubMed27129254
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com